Zhen-Wei Deng Selected Research

peptide PVA

1/2022

MMP-responsive transformation nanomaterials with IAP antagonist to boost immune checkpoint therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhen-Wei Deng Research Topics

Disease

4	Neoplasms (Cancer) 04/2024 - 01/2021
1	Breast Neoplasms (Breast Cancer) 04/2024
1	Neoplasm Metastasis (Metastasis) 04/2024
1	Melanoma (Melanoma, Malignant) 04/2024
1	Hypoxia (Hypoxemia) 01/2021
1	Stomach Neoplasms (Stomach Cancer) 04/2015

Drug/Important Bio-Agent (IBA)

2	Peptides (Polypeptides)IBA 04/2024 - 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2024
1	peptide PVAIBA 01/2022
1	EnzymesIBA 01/2022
1	ChemokinesIBA 01/2022
1	Matrix Metalloproteinases (MMPs)IBA 01/2022
1	Oxygen (Dioxygen)IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	ElementsIBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	Cancer VaccinesIBA 01/2021
1	SolutionsIBA 04/2015

Therapy/Procedure

3	Therapeutics 04/2024 - 01/2021
2	Immunotherapy 01/2022 - 01/2021
1	Photothermal Therapy 04/2024
1	Precision Medicine 01/2021
1	Gastrectomy 04/2015